Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,172

Participants

Timeline

Start Date

August 31, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions
MalariaMalaria in PregnancyPregnancy Related
Interventions
DRUG

Dihydroartemisinin-Piperaquine (DP)

DP (D-Artepp) will be supplied by Fosun Pharma, China. DP will consist of three 40mg/320mg) tablets given once a day for three consecutive days

DRUG

Sulfadoxine pyrimethamine (SP)

SP (G-COSPE) will be supplied by Fosun Pharma, China. SP will be given as a single dose consisting of three 500mg/25mg tablets.

Trial Locations (1)

511

Papua New Guinea Institute of Medical Research, Madang

All Listed Sponsors
collaborator

Papua New Guinea Institute of Medical Research

OTHER_GOV

collaborator

University of Melbourne

OTHER

collaborator

Curtin University

OTHER

collaborator

Liverpool School of Tropical Medicine

OTHER

lead

Menzies School of Health Research

OTHER